Legend: No confirmed case With confirmed case No case based data

Similar documents
Legend: No confirmed case With confirmed case** No case based data

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 March 2018, WHO Western Pacific Region

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 December 2017, WHO Western Pacific Region

Legend: No confirmed case With confirmed case No case based data

Legend: No confirmed case With confirmed case No case based data

Legend: No confirmed case With confirmed case No case based data

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 December 2018, WHO Western Pacific Region

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 December 2014, WHO Western Pacific Region

Figure 1. Distribution of confirmed measles cases with rash onset 1 30 September 2014, WHO Western Pacific Region

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 August 2014, WHO Western Pacific Region

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 July 2014, WHO Western Pacific Region

Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 31 March 2014

Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 30 January 2014

Measles cases MCV1 coverage MCV2 coverage

Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,

World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 13 September 2007 ISSN

Polio Bulletin 2014 Issue No Week 25 (as of 23 Jun 2014)

BULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January 2006 ISSN

BULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 11 December 2006 ISSN

BULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 10 August 2006 ISSN

2009 Report. Tuberculosis Control. in the Western Pacific Region

TUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION In the WHO Western Pacific Region 2002 Report

Bi-weekly Influenza Situation Update

Essential Medicines. WHO

Training Workshop Report

REGIONAL OFFICE FOR THE WESTERN PACIFIC BUREAU RÉGIONAL DU PACIFIQUE OCCIDENTAL MEASLES ELIMINATION

Bi-weekly Influenza Situation Update

Update on the Dengue situation in the Western Pacific Region

Bi-weekly Influenza Situation Update

Bi-weekly Influenza Situation Update

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

2010 Report. Tuberculosis Control. in the Western Pacific Region

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

TUBERCULOSIS CONTROL WHO WESTERN PACIFIC REGION

SEVERE ACUTE RESPIRATORY SYNDROME (SARS) Regional Response

Action Plan to Reduce the Double Burden of Malnutrition in the Western Pacific Region. Dr Katrin Engelhardt, MPH Technical Lead, Nutrition DNH/WPRO

REVIEW OF TUBERCULOSIS EPIDEMIOLOGY

INTERNATIONAL HEALTH REGULATIONS

Global Measles and Rubella Update November 2018

Global Measles and Rubella Update October 2018

Update on the Dengue situation in the Western Pacific Region

Meeting Report SIXTH ANNUAL MEETING OF THE REGIONAL VERIFICATION COMMISSION FOR MEASLES ELIMINATION IN THE WESTERN PACIFIC

Western Pacific Regional Office of the World Health Organization

Expanded Programme on Immunization

Dengue Situation Update Number 534. Update on the Dengue situation in the Western Pacific Region

Meeting Report. Fourth Meeting on Vaccine Preventable Diseases Laboratory Networks in the Western Pacific Region March 2013 Manila, Philippines

Update on the Dengue situation in the Western Pacific Region

Dengue Situation Update Number Update on the Dengue situation in the Western Pacific Region

Update on the Dengue situation in the Western Pacific Region

Global Measles and Rubella Update. April 2018

Influenza Situation Update

Update on the Dengue situation in the Western Pacific Region

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594

Western Pacific Regional Office of the World Health Organization.

Dengue Situation Update Number Update on the Dengue situation in the Western Pacific Region

Update on the Dengue situation in the Western Pacific Region

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093

宮村参考人提出資料 資料 2-2

Influenza surveillance summary

Update on the Dengue situation in the Western Pacific Region

Western Pacific Region. Maintaining polio-free status

WHO priorities for 2016 in US PICTs

Influenza Situation Update

Measles and Rubella Global Update SAGE April 2018

Meeting Report May 2015 Manila, Philippines

Update on the Dengue situation in the Western Pacific Region

2006 Report. Tuberculosis Control. in the Western Pacific Region

Dengue Situa0on Update Number 521. Update on the Dengue situa0on in the Western Pacific Region

Influenza Situation Update

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000

Bi-weekly Influenza Situation Update

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210

Influenza Situation Update

Influenza Situation Update

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100


Population. B.4. Malaria and tuberculosis

Western Pacific Regional Office of the World Health Organization WPRO Dengue Situation Update, 2 October 2013 Recent Cumulative No.

The Global Burden of Viral Hepatitis

Influenza Situation Update

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)

WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR THE WESTERN PACIFIC

Dengue, an emerging arboviral infection, continues

Table 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712.

Expanded Programme on Immunization (EPI)

Training Report. Fourth Hands-on Training Workshop on the Laboratory Diagnosis of Japanese Encephalitis in the Western Pacific Region

OF MEASLES ELIMINATION

World Health Organization. Regional Office for the Western Pacific STI

In recent years, dengue has become a major public

Noncommunicable Diseases in the Western Pacific Region. A Profile

Update on the dengue situation in the Western Pacific Region

Tuberculosis Control

ANNUAL REPORT ON AIDS, INCLUDING SEXUALLY TRANSMITTED DISEASES

CANCER FACT SHEETS: LIVER CANCER

CANCER FACT SHEETS: BREAST CANCER

Western Pacific Regional Office of the World Health Organization

PROJECT DOCUMENT. Cooperative Agreement for Preventing the Spread of Communicable Diseases through Air Travel (CAPSCA)

Meeting Report. 29 September to 1 October 2015 Nadi, Fiji

WHO s regional strategies: HIV, STI and Viral Hepatitis

Professor Glen Mola Head of Reproductive Health, Obstetrics and Gyneology School of Medicine and Health Sciences, UPNG

Transcription:

Volume 11 Issue 10 ober ISSN 1814 3601 Figure 1. Distribution of measles with rash onset 1 30 tember, WHO Western Pacific Region Legend: No case With case No case based data Dots are placed at rom within the corresponding district, might not reflect the exact location of the case DISCLAIMER: The boundaries names shown the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO Regional Office for the Western Pacific 2009. All rights reserved *Map of Australia is from the Australian Bureau of Statistics Source: rubella monthly country reports to the Western Pacific Regional Office by 20 ober Table 1. Confirmed measles by month of rash onset, ober tember, WHO Western Pacific Region Nov Dec Australia 7 6 16 9 7 25 7 4 0 2 4 13 Brunei Darussalam 0 0 0 0 0 0 0 0 0 0 0 0 Cambodia 9 12 10 4 5 0 0 0 1 0 0 0 China 208 222 531 306 437 651 830 809 532 381 306 283 China, Hong Kong SAR 0 0 3 1 1 0 1 0 0 0 0 1 China, Macao SAR 0 0 0 0 0 0 0 0 0 2 0 0 Japan 10 2 5 16 26 68 46 3 3 2 7 4 Lao People's Democratic Republic 0 0 8 3 0 0 0 0 0 0 0 0 Malaysia 78 60 67 74 57 120 140 184 126 175 163 75 Mongolia 2 2 4 2 1 4 2 0 0 0 0 0 New Zeal 1 0 0 6 2 2 0 4 0 0 0 0 Papua New Guinea 0 0 0 0 0 0 0 0 0 0 2 4 Philippines 8 4 3 4 3 10 7 4 4 7 37 47 Republic of Korea 4 0 0 1 0 2 0 1 0 0 0 0 Singapore 11 24 16 9 10 9 5 6 7 2 2 5 Viet Nam 2 0 0 1 0 0 3 1 0 0 0 0 Pacific isl countries areas 0 0 0 0 0 0 0 1 0 0 0 0 Western Pacific Region 340 332 663 436 549 891 1041 1017 673 571 521 432 "-" No data Source: Case based aggregate data reports to the Western Pacific Regional Office by 20 ober

Nov Dec Nov Dec Nov Dec Nov Dec Nov Dec Number of measles Figure 2. Confirmed compatible measles by month of rash onset, WHO Western Pacific Region, 2012 as of 20 ober 25 000 20 000 15 000 10 000 5 000 0 2012 2013 2014 2015 China Malaysia Mongolia Papua New Guinea Philippines Viet Nam Others Source: rubella monthly country reports to WHO by 20 ober Includes laboratory, epi-linked clinically for 2012 Table 2. Status of measles verification, WHO Western Pacific Region Source of infection % of Source of infection % of Year with with Imported Importrelated source of related source of Unknown / not Endemic Imported Import- Unknown verified known known / not Endemic reported infection reported infection Australia 2014 99 31 18 50 0 49.5% 71 34 27 10 0 85.9% Brunei Darussalam 2015 1 1 0 0 0 100.0% 0 - - - - - Cambodia 2015 56 0 0 56 0 0.0% 10 0 0 10 0 0.0% China - 23 960 0 0 23 960 0 0.0% 4 535 0 0 4 535 0 0.0% China, Hong Kong SAR 9 1 0 8 0 11.1% 4 3 0 1 0 75.0% China, Macao SAR 2014 0 - - - - - 2 0 2 0 0 100.0% Japan 2015 152 27 97 28 0 81.6% 175 32 128 15 0 91.4% Lao People's Democratic Republic - 8 0 0 8 0 0.0% 3 0 0 3 0 0.0% Malaysia - 1 577 5 0 69 1 503 95.6% 1 114 4 0 709 401 36.4% Mongolia - 3 587 0 2 392 0 1 195 100.0% 9 0 0 0 9 100.0% New Zeal - 104 0 0 104 0 0.0% 14 0 0 14 0 0.0% Papua New Guinea - 0 - - - - - 6 0 0 6 0 0.0% Philippines - 74 1 0 53 20 28.4% 123 0 0 100 23 18.7% Republic of Korea 2014 18 9 9 0 0 100.0% 4 3 0 1 0 75.0% Singapore - 140 16 90 34 0 75.7% 55 13 22 20 0 63.6% Viet Nam - 36 0 0 36 0 0.0% 5 0 0 5 0 0.0% Pacific isl countries areas - 6 0 0 6 0 0.0% 1 0 0 1 0 0.0% 29 827 91 2 606 24 412 2 718 18.2% 6 131 89 179 5 430 433 11.4% Blue No measles Green 80% Yellow 60 79% Red <60% Source: rubella monthly country reports to WHO by 20 ober 2

Table 3. case classification incidence by country area, WHO Western Pacific Region, 2013 as of 20 ober 2013 2014 2015 Rash compatible 1 incidence per 1 million pop. compatible 1 incidence per 1 million pop. compatible 1 incidence per 1 million pop. compatible 1 incidence per 1 million pop. Population (in millions) 2 Suspected measles Pending classification Confirmed compatible measles Discarded Compatible 3 Lab Epi-linked Annualized measles incidence per compatible 1 million pop. Deaths due to measles onset of last measles case Australia 154 6.6 340 14.5 74 3.3 99 4.1 24.6 NA 3 0 0 0 68 3 71 3.8 0 27--17 Brunei Darussalam 0 0.0 0 0.0 4 9.0 1 2.3 0.4 10 0 10 0 0 0 0 0.0 0 7--16 Cambodia 0 0.0 0 0.0 0 0.0 56 3.5 16.1 517 37 470 0 10 0 10 0.8 0 8--17 China 27825 20.5 52 485 38.5 42 864 30.7 24 839 18.0 1388.2 26 554 337 20 854 828 4 485 50 5 363 5.2 5 30--17 China, Hong Kong SAR 38 5.2 50 6.8 18 2.4 9 1.2 7.4 14 0 10 0 4 0 4 0.7 0 27--17 China, Macao SAR 3 5.2 1 1.7 0 0.0 0 0.0 0.6 15 0 13 0 2 0 2 4.4 0 21--17 Japan 207 1.6 454 3.6 35 0.3 157 1.2 126.0 572 0 394 3 175 0 178 1.9 0 25--17 Lao People's Democratic Republic 68 10.5 70 10.7 56 8.0 8 1.2 7.0 355 78 274 0 2 1 3 0.6 0 10--17 Malaysia 182 6.1 222 7.3 1 318 43.9 1 587 51.6 31.2 6 173 708 4 318 33 1 097 17 1 147 49.1 0 24--17 Mongolia 0 0.0 0 0.0 20 374 7136.8 28 813 9583.7 3.1 120 0 111 0 9 0 9 3.9 0 5--17 New Zeal 13 2.9 274 60.2 13 2.9 104 22.8 4.6 31 7 10 0 11 3 14 4.1 0 25--17 Papua New Guinea 7 1.0 2 589 345.9 53 6.9 0 0.0 7.9 27 0 21 0 6 0 6 1.0 0 22--17 Philippines 5798 59.1 54 669 548.0 2 003 19.7 641 6.3 103.8 2 673 90 1 802 658 123 0 781 10.0 0 21--17 Republic of Korea 107 2.2 442 9.0 7 0.1 18 0.4 50.7 185 2 179 0 4 0 4 0.1 0 1--17 Singapore 66 12.5 171 32.0 45 8.9 157 27.6 5.8 130 0 64 11 55 0 66 15.2 0 24--17 Viet Nam 1232 13.6 16 741 182.8 884 9.4 368 3.9 95.4 916 29 715 167 5 0 172 2.4 0 17--17 Pacific isl countries areas 4 0 0.0 278 85.0 20 6.1 6 1.8 3.3 66 3 62 0 1 0 1 0.4 0 1--17 Western Pacific Region 35 700 19.5 128 786 70.1 67 768 36.2 56 863 30.5 1876.2 38 358 1 291 29 307 1 700 6 057 74 7 831 5.6 5 1 Includes compatible, laboratory epi-linked Green <1 measles case / 1 000 000 population 2 United Nations, Department of Economic Social Affairs, Population Division World Population Prospects. Yellow 1 9.9 measles case / 1 000 000 population 3 Australia reports only. Red >= 10 / 1 000 000 population 4 Classification is provisional based on laboratory data only. 3

Table 4. surveillance performance indicators by country area, WHO Western Pacific Region, as of 20 ober Discarded non-measles rate per 100 000 pop Second level units with 2 discarded per 100 000 pop [annualized] 1 Suspected with adequate investigation Suspected with adequate specimens for laboratory confirmation 2 Annualized discarded non-measles rate per 100 000 pop Second level units with 2 discarded per 100 000 pop [annualized] 1 Suspected with adequate investigation Suspected with adequate specimens for laboratory confirmation 2 2 80% 80% 80% 2 80% 80% 80% Australia 3 Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Brunei Darussalam 2.8 Not applicable 100.0% 100.0% 0.0 Not applicable 100.0% 110.0% Cambodia 4.2 72.0% 88.3% 99.0% 3.9 72.0% 89.6% 96.5% China 3.2 77.4% 97.1% 87.9% 2.0 51.6% 97.3% 89.6% China, Hong Kong SAR 2.5 Not applicable 97.9% 99.5% 0.0 Not applicable 100.0% 100.0% China, Macao SAR 2.0 Not applicable 100.0% 100.0% 2.9 Not applicable 100.0% 100.0% Japan 0.7 4.3% Insufficient data Insufficient data 0.4 0.0% Insufficient data Insufficient data Lao People's Democratic Republic 7.3 70.6% 98.6% 47.6% 5.2 70.6% 87.9% 88.7% Malaysia 16.1 93.8% 79.6% 88.6% 18.5 93.8% 78.4% 87.3% Mongolia 46.4 95.5% 8.0% 14.4% 4.8 4.5% 92.5% 92.5% New Zeal 1.1 Insufficient data Insufficient data Insufficient data 0.3 Insufficient data Insufficient data Insufficient data Papua New Guinea 0.6 10.0% 65.3% 89.8% 0.4 5.0% 92.6% 74.1% Philippines 1.5 17.6% 57.3% 70.2% Not available 35.3% 30.9% 72.2% Republic of Korea 0.6 0.0% 92.1% 79.9% 0.5 0.0% 96.2% 94.1% 4 Singapore 1.6 Not applicable 85.1% 51.8% 1.5 Not applicable 70.8% 69.2% Viet Nam 1.2 22.2% 56.9% 77.9% 1.0 25.4% 55.2% 77.6% Pacific isl countries areas 7.8 13.0% 90.9% 90.1% 2.5 13.0% 86.4% 95.5% Western Pacific Region 3.0 39.0% 70.9% 67.7% 2.1 29.6% 88.2% 88.2% 1 This indicator is not applicable for countries which have no second-level administrative units 2 Adequate specimen defined as blood specimen collected within 28 days of rash onset or other specimen (throat swab, nasopharyngeal swab, cerebrospinal fluid, urine) collected within 5 days of rash onset; excludes epidemiologically-linked. 3 Reports only. Green Yellow Red Reached or surpassed target Nearly reached target: 1.00 1.99 for non-measles suspected case rate; 10.1 25% for percent clinically ; 60 79% for other indicators Substantially below target 24

Table 5. case classification incidence by country area, WHO Western Pacific Region, 2014 as of 20 ober compatible 2014 2015 incidence per 1 million pop. compatible Population Investigated Pending incidence per incidence per (in millions) 1 for rubella classification 1 million pop. 1 million pop. compatible Confirmed compatible rubella Annualized Congenital Discarded Compatible rubella rubella Lab Epi-linked incidence per syndrome compatible 1 million pop. Australia - - - - - - 24.64 - - - - - - - - - Brunei Darussalam 0 0.0 0 0.0 0 0.0 0.43 11 0 11 0 0 0 0 0.0 - Cambodia 31 2.1 18 1.1 4 0.3 16.08 480 0 475 0 5 0 5 0.4 - China 11 887 8.7 8 245 5.9 4 476 3.2 1 388.23 26 554 - - - - - 1 376 1.3 - China, Hong Kong SAR 1 0.1 12 1.6 3 0.4 7.40 0 - - - - - 0 0.0 - China, Macao SAR 0 0.0 2 3.5 1 1.7 0.61 15 0 15 0 0 0 0 0.0 - Japan - - 2 0.0 3 0.0 126.05 52 0 48 0 4 0 4 0.0 - Lao People's Democratic Republic 18 2.8 24 3.4 40 5.8 7.04 355 78 267 0 7 3 10 1.9 - Malaysia 226 7.5 34 1.1 68 2.2 31.16 6 197 708 5 403 0 86 0 86 3.7 - Mongolia 0 0.0 28 9.8 27 9.0 3.05 114 0 93 0 12 0 12 5.2 - New Zeal - - - - - - 4.60 - - - - - - - - - Papua New Guinea - - 4 0.5 2 0.3 7.93 22 16 6 0 0 0 0 0.0 - Philippines 343 3.4 154 1.5 165 1.6 103.80 2 673 90 2 154 0 412 17 429 5.5 - Republic of Korea 2 0.0 2 0.0 3 0.1 50.70 196 2 185 0 0 0 0 0.0 - Singapore 0 0.0 1 0.2 0 0.0 5.78 3 0 0 0 3 0 3 0.7 - Viet Nam 50 0.5 972 10.4 350 3.7 95.41 751 28 670 12 40 0 40 0.6 - Pacific isl countries areas 2 4 1.2 0 0.0 1 0.3 3.28 66 3 57 0 4 0 4 1.6 - Western Pacific Region 675 0.4 1 253 0.7 667 0.4 1 876.21 37 489 925 9 384 12 573 20 1 969 1.4-1 United Nations, Department of Economic Social Affairs, Population Division World Population Prospects. Green <1 measles case / 1 000 000 population 2 Classification is provisional based on laboratory data only. Yellow 1 9.9 measles case / 1 000 000 population "-" No data Red >= 10 / 1 000 000 population Gray No data 5

Table 6A. rubella laboratory testing, WHO Western Pacific Region, as of 20 ruary No. No. % No. % No. received Australia VIDRL 92 92 67 22 14 63.6 4 18% 0-72.7 0-66 60 58 7 2 28.6 0 0% Brunei Darussalam DLS 16 16 13 13 1 7.7 1 8% 0-92.3 0-1 1 1 13 0 0.0 0 0% Cambodia NIPH 719 719 719 596 54 9.1 0 0% 123 2 80.9 0-0 - 44 719 4 0.6 0 0% China CCDC - - - - - - - - - - 89.0 - - - - - - - - - - China, Hong Kong SAR PHLC 600 600 509 538 9 1.7 16 3% 0-93.0 5 4 64 20 12 535 3 0.6 3 1% China, Macao SAR PHL 46 46 46 46 3 6.5 2 4% 0-100.0 0-1 0 3 46 4 8.7 1 2% Japan NIID 1 585 1 398 802 206 44 21.4 34 17% 0 - - 0-669 146 156 10 1-0 0% Lao People's Democratic Republic NCLE 254 254 254 254 2 0.8 4 2% 0-80.7 0-0 - 0 254 8 3.1 9 4% Malaysia NPHL 8 579 6 593 6 593 6 256 1 620 25.9 180 3% 0-93.6 1 264 122 0-1 662 4 513 108 2.4 53 1% Mongolia NCCD 10 031 10 031 9 996 9 749 4 969 51.0 981 10% 0-99.8 1 0 286 142 5 076 6 506 31-15 0% New Zeal CHL 842 842 757 221 22 10.0 10 5% 0-98.2 1 0 590 68 79 157 1 0.6 0 0% Papua New Guinea CPHL 40 40 40 40 0-0 0% 0-7.5 0-0 - 0 40 1 2.5 2 5% Philippines RITM 1 612 1 612 1 610 1 524 36 2.4 31 2% 51 5 98.9 62 0 62 0 40 1 576 110 7.0 62 4% Republic of Korea KCDC 633 633 530 400 51 12.8 33 8% 0-82.9 0-222 17 55 244 25 10.2 18 7% Singapore SGH 813 813 724 243 25 10.3 0 0% 0-100.0 186 6 0-25 347 2 0.6 0 0% Viet Nam national lab (Northern) NIHE 332 332 318 313 1 0.3 1 0% 0-96.1 10 0 19 0 1 313 31 9.9 15 5% Viet Nam national lab (Southern) PI 870 870 868 865 39 4.5 20 2% 0-85.2 5 0 5 0 39 865 384 44.4 24 3% Viet Nam subnational lab (Central) PI 183 183 183 182 2 1.1 1 1% 0-51.1 0-1 0 2 182 10 5.5 3 2% Viet Nam subnational lab (Highl) IHE 77 77 77 77 0-0 0% 0-20.8 0-0 - 0 77 0 0.0 1 1% Fiji FCCDC 243 243 243 233 5 2.1 4 2% 9 0-0 - 0-5 243 1 0.4 0 0% Vanuatu FCCDC 15 15 15 15 0 0.0 0 0% 15 0-0 - 0-0 15 0 0.0 1 7% 27 582 25 409 24 364 21 793 6 897 31. 6 1 322 6% 198 7 95.1 1 534 132 1 986 454 7 258 16 662 726 4.4 207 1% "-" No data Laboratory of received rubella of of Samples for measles IgM Serum IgM (+) Serology IgM equiv Blood DBS No. (+) % of with results 4 days Virus detection Virus isolation/ detection (swab, urine others) isolates Reverse Transcription- Polymerase Chain Samples of for IgM (+) lab IgM equiv rubella IgM Reaction No. (+) No. No. % No. % Serum blood (includes DBS) 6

Table 6B. rubella laboratory testing, WHO Western Pacific Region, as of 20 ober No. No. % No. % No. received Australia VIDRL 70 70 59 9 6 66.7 1 11% 0-100.0 1 0 62 61 58 1 0-0 - Brunei Darussalam DLS 12 12 12 12 0 0.0 2 17% 0-100.0 0-0 - 0 12 0 0.0 0 0% Cambodia NIPH 858 858 858 667 10 1.5 0 0% 191 0 63.0 0-0 - 10 857 5 0.6 0 0% China CCDC - - - - - - - - - - 91.2 - - - - - - - - - - China, Hong Kong SAR PHLC 228 228 191 193 4 2.1 4 2% 0-93.4 7 3 39 9 5 184 0 0.0 1 1% China, Macao SAR PHL 51 51 51 51 3 5.9 2 4% 0-100.0 0-4 2 3 51 0 0.0 1 2% Japan NIID 978 938 533 125 37 29.6 19 15% 0 - - 0-473 166 175 7 0-0 0% Lao People's Democratic Republic NCLE 268 268 268 268 2 0.7 8 3% 0-82.5 0-0 - 2 266 11 4.1 9 3% Malaysia NPHL 9 105 9 105 6 928 6 591 1 370 20.8 182 3% 0-95.0 1 366 93 0-1 406 5 044 140 2.8 122 2% Mongolia NCCD 544 544 544 544 3 0.6 13 2% 0-100.0 0-6 0 0 521 6 1.2 28 5% New Zeal CHL 286 286 262 110 4 3.6 6 5% 0-98.2 0-155 10 10 108 0 0.0 0 0% Papua New Guinea CPHL 11 11 11 11 5 45.5 0 0% 0-90.9 0-0 - 0 5 0 0.0 0 0% Philippines RITM 2 070 2 036 2 059 1 943 109 5.6 25 1% 60 9 97.3 123 0 173 2 109 1 994 302 15.1 126 6% Republic of Korea KCDC 383 383 307 240 25 10.4 15 6% 0-84.2 0-119 2 26 138 28 20.3 20 14% Singapore NPHL 394 394 380 74 9 12.2 2 3% 0-100.0 41 15 300 41 49 75 8 10.7 0 0% Viet Nam national lab (Northern) NIHE 401 401 401 395 3 0.8 4 1% 0-97.5 5 0 6 0 3 395 12 3.0 17 4% Viet Nam national lab (Southern) PI 224 224 224 224 4 1.8 2 1% 0-83.9 0-0 - 4 224 28 12.5 10 4% Viet Nam subnational lab (Central) PI 125 125 125 125 0-2 2% 0-28.0 0-0 - 0 125 2-0 0% Viet Nam subnational lab (Highl) IHE 33 33 33 33 0-0 0% 0-24.2 0-0 - 0 33 0 0.0 0 0% Fiji FCCDC 63 63 63 58 1 1.7 0 0% 3 0-0 - 0-1 60 3 5.0 1 2% 16 104 16 030 13 309 11 673 1 595 13. 7 287 2% 254 9 91.9 1 543 111 1 337 293 1 861 10 100 545 5.4 335 3% "-" No data Laboratory of received rubella of of Samples for measles IgM Serum IgM (+) Serology IgM equiv Blood DBS No. (+) % of with results 4 days Virus detection Virus isolation/ detection (swab, urine others) isolates Reverse Transcription- Polymerase Chain Samples of for IgM (+) lab IgM equiv rubella IgM Reaction No. (+) No. No. % No. % Serum blood (includes DBS) 7

Figure 3. genotype distribution of with rash onset in, WHO Western Pacific Region B3 D4 D8 D9 The boundaries names shown the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO Regional Office for the Western Pacific 2009. All rights reserved. D11 G3 H1 Table 7. genotype distribution of with rash onset in ober to tember, WHO Western Pacific Region Nov Dec B3 D8 D9 H1 B3 D4 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 Australia 8 1 7 8 15 2 4 11 12 3 1 2 1 1 Brunei Darussalam Cambodia 4 2 5 7 1 3 China 2 3 11 47 39 1 71 5 67 1 65 1 19 16 12 5 China, Hong Kong SAR 2 1 1 1 China, Macao SAR 2 Japan 10 1 1 8 14 1 1 16 1 2 52 2 51 1 2 8 2 Lao People's Democratic Republic Malaysia 1 3 1 1 Mongolia New Zeal 1 3 4 1 2 Papua New Guinea Philippines 2 1 Republic of Korea 3 1 Singapore 2 3 16 2 10 2 5 2 2 4 3 6 1 1 4 1 2 2 1 Viet Nam Pacific isl countries areas Sources: Includes all reported to the Western Pacific Regional Office by 20 ober the Nucleotide Surveillance online database (MeaNS). 8

Figure 4. genotype distribution of with rash onset in, WHO Western Pacific Region 2B 1E 9 The boundaries names shown the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO Regional Office for the Western Pacific 2009. All rights reserved. Table 8. genotype distribution of with rash onset in ober to tember, WHO Western Pacific Region Nov Dec 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J Australia 1 Brunei Darussalam Cambodia China 2 18 6 2 11 4 15 5 China, Hong Kong SAR 1 China, Macao SAR Japan 1 1 1 Lao People's Democratic Republic Malaysia Mongolia New Zeal 1 Papua New Guinea Philippines 6 1 5 4 9 14 4 Republic of Korea Singapore 1 1 1 Viet Nam Pacific isl countries areas Sources: Includes all reported to the Western Pacific Regional Office by 20 ober the Nucleotide Surveillance online database (RubeNS).

Table 9A. Completeness timeliness of epidemiologic reporting, WHO Western Pacific Region, 1 Country 1 Completeness 2 Timeliness 3 Completeness 2 Timeliness 3 Australia 100% 75% 10 09 10 10 09 10 09 06 10 100% 100% Brunei Darussalam 100% 100% 07 06 08 06 06 08 08 07 07 100% 100% Cambodia 100% 100% 10 10 10 10 10 10 10 10 10 100% 100% China 100% 83% 15 11 18 10 04 15 15 11 15 100% 89% China, Hong Kong SAR 100% 100% 10 09 06 02 06 04 07 06 09 100% 100% China, Macao SAR 100% 100% 07 07 05 05 02 07 10 07 09 100% 100% Japan 100% 100% 06 09 10 10 09 08 10 09 10 100% 100% Lao People's Democratic Republic 100% 100% 10 10 10 10 10 10 10 10 10 100% 100% Malaysia 100% 100% 07 09 10 09 09 07 10 08-05 100% 100% Mongolia 100% 83% 09 07 06 09 07 03 07 10 10 100% 100% New Zeal 100% 100% 09 07 07 05 08 03 07 05 03 100% 100% Papua New Guinea 92% 50% 08 08 13 10 09 10 08 07 10 89% 89% Philippines 100% 75% - - 31 05 10 14 08-18 100% 33% Republic of Korea 100% 100% 10 09 10 10 08 07 09 07 10 100% 100% Singapore 100% 100% 08 09 10 08 09 10 10 10 05 100% 100% Viet Nam 100% 92% 09 10 07 09 08 03 08 08 09 100% 100% Pacific isl countries areas 100% 100% 14 14 13 15 16 12 17 18 14 100% 67% Completeness 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Timeliness 92% 94% 94% 88% 100% 94% 94% 94% 88% 94% 93% 1 National measles surveillance monthly reports from tember. Legend: black = timely report; red = untimely report 2 Completeness is defined as the of reports received by the end of the reporting month divided by the of expected reports for the year. 3 Countries areas should submit reports by the 10th (or the next working day) of the following month; Pacific isl countries areas China may report to the Regional Office by the 15th (or the next working day) of the following month. Table 9B. Completeness timeliness of laboratory reporting, WHO Western Pacific Region, 1 Genotype results by source of data Completeness 2 Timeliness 3 Completeness 2 Timeliness 3 MeaNS Submission to WPRO Rubens Submission to WPRO Australia 100% 100% 03 06 04 02 06 04 03 07 06 100% 100% 62 38 1 0 Brunei Darussalam 100% 100% 04 02 03 29 01 03 31 04 07 100% 100% 0 0 0 0 Cambodia 100% 100% 10 10 10 10 10 10 10 10 10 100% 100% 0 4 0 0 China 100% 100% 03 06 10 03 06 03 08 06 06 100% 100% 346 346 43 46 China, Hong Kong SAR 100% 100% 09 07 06 05 07 06 07 06 09 100% 100% 3 4 0 0 China, Macao SAR 100% 100% 07 08 07 05 02 07 10 08 10 100% 100% 0 2 0 0 Japan 100% 100% 06 09 10 10 09 08 10 09 10 100% 100% 140 153 3 0 Lao People's Democratic Republic 100% 100% 10 10 10 10 10 10 10 10 10 100% 100% 0 0 0 0 Malaysia 100% 83% 08 09 10 09 08 07 10 08 10 100% 100% 6 0 0 0 Mongolia 92% 67% 10 06 10 10 10 07 10 10 10 100% 100% 0 0 0 0 New Zeal 100% 100% 09 07 07 05 08 03-07 07 03 100% 100% 10 7 1 1 Papua New Guinea 100% 33% 13 10 10 10 15 10 15 18 06 100% 56% 0 0 0 0 Philippines 100% 92% 21 08 07 10 08 07 08 10 09 100% 89% 4 2 43 30 Republic of Korea 100% 100% 10 10 10 10 09 07 10 07 10 100% 100% 1 1 0 0 Singapore 100% 100% 08 09 10 08 09 10 10 10 05 100% 100% 39 37 3 3 Viet Nam national lab (Northern) 100% 92% 07 07 03 10 02 10 01 08 10 100% 100% 0 0 0 0 Viet Nam national lab (Southern) 100% 100% 10 08 07 05 09 10 04 07 09 100% 100% 0 0 0 0 Viet Nam subnational lab (Central) 100% 92% 07 07 03 10 02 10 01 08 10 100% 100% 0 0 0 0 Viet Nam subnational lab (Highl) 100% 92% 07 07 03 10 02 10 01 08 10 100% 100% 0 0 0 0 Fiji 100% 92% 14 14 13 15 16 10 17 18 14 100% 67% 0 0 0 0 Completeness 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Timeliness 92% 100% 100% 95% 100% 90% 100% 90% 90% 100% 95% 611 594 94 80 1 National measles laboratory monthly reports from tember. Legend: black = timely report; red = untimely report 2 Completeness is defined as the of reports received by the end of the reporting month divided by the of expected reports for the year. 3 National measles rubella laboratories should submit monthly reports by the 10th (or the next working day) of the following month. Exped Programme on Immunization Regional Office for the Western Pacific World Health Organization P.O. Box 2932, 1000 Manila, Philippines Tel. No. (63 2) 5288001 Fax No. (63 2) 5211036, 5260279 Please send your comments monthly data before the 10th of the month to: WPROEPIdata@who.int More detailed information available in the Regional country profile of measles elimination 10